 failur ciprofloxacin convalesc fecal excret acut salmonellosi experi outbreak health care worker object efficaci ciprofloxacin therapi convalesc fecal excret salmonella acut salmonellosi design placebo-control double-blind trial ciprofloxacin prospect follow-up nonparticip set acut care commun hospit outbreak salmonellosi patient twenty-eight health care worker acut infect salmonella java placebo-control trial ciprofloxacin day infect intervent patient ciprofloxacin mg patient placebo twice day nonparticip therapi ciprofloxacin regimen measur main result studi particip follow-up stool cultur day week nonparticip consecut cultur neg ciprofloxacin recipi erad java stool cultur day therapi placebo recipi stool cultur neg day therapi stool cultur posit day therapi addit hospit patient ciprofloxacin control trial total relaps rate CI patient relaps durat fecal excret salmonella placebo group relaps basi noncompli develop resist presenc biliari diseas conclus excel antimicrobi activ salmonella favor pharmacokinet profil ciprofloxacin dosag mg high failur rate patient acut salmonellosi fecal excret salmonella late occurr relaps need stool day therapi fecal erad acut salmonellosi